Association between craniosynostosis and phospholipid metabolism: Insights from single-cell and transcriptomic analysis
Open Access
- 27 March 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (13) , e48030
Abstract
: Craniosynostosis is a common defect in the craniofacial structure of children, yet its pathogenesis remains unclear. Current research focuses mainly on bone-related genetic mutations, with less emphasis on lipid metabolism disorders. Hence, it is imperative to investigate the underlying mechanisms from various perspectives. We investigated the association between craniosynostosis and phospholipid metabolism through a multi-omics approach. This included Mendelian randomization (MR) to assess causal relationships of lipid traits, transcriptomic differential analysis of clinical samples, and single-cell RNA sequencing of murine cranial sutures to identify key cell subtypes. Furthermore, drug-target MR and network pharmacology were conducted to explore the potential therapeutic repurposing of statins. MR analysis revealed a significant protective effect of phospholipids in very low-density lipoprotein remnants against craniosynostosis. Drug-target MR targeting HMGCR indicated a protective trend (OR = 0.79) for statins, consistent with the lipid-metabolic link, although statistical significance was limited by sample size. Transcriptomic analysis identified MORN5 as a key upregulated gene enriched in glycerophospholipid metabolism. Single-cell RNA sequencing identified a specific osteogenic subtype (C4) and lipid-metabolic subtypes (C5/C6) driving the disease. Pharmacological prediction and molecular docking further suggested that Rosuvastatin could target MORN5 and epidermal growth factor receptor, showing high binding affinity (<−5 kcal/mol). Our findings provide robust evidence that phospholipid metabolism plays a critical role in craniosynostosis. While the genetic evidence for statins is exploratory, the consistent protective trend and molecular docking results suggest a potential therapeutic avenue that warrants further investigation in larger cohorts and experimental models.Keywords
This publication has 24 references indexed in Scilit:
- Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adultsOsteoporosis International, 2023
- Spatial Lipidomic Profiling of Mouse Joint Tissue Demonstrates the Essential Role of PHOSPHO1 in Growth Plate HomeostasisJournal of Bone and Mineral Research, 2020
- Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targetsDrug Resistance Updates, 2020
- Metabolic reprogramming in osteoclastsSeminars in Immunopathology, 2019
- Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPANature Communications, 2016
- The regulation of osteoclast differentiation by Wnt signalsBoneKEy Reports, 2015
- Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1Nature Structural & Molecular Biology, 2011
- Differential activation of canonical Wnt signaling determines cranial sutures fate: A novel mechanism for sagittal suture craniosynostosisDevelopmental Biology, 2010
- Mechanics of membrane fusionNature Structural & Molecular Biology, 2008
- Histopathological and biochemical changes in the sutural region in craniosynostosisChild's Nervous System, 2000